During the first year of the project, Spotlab has worked in the achievement of a version of its technology platform ready for the clinical performance evaluation studies with new critical functionalities and testing protocols. The industrialization process has followed the medical device design and development guidelines from the ISO13485 and will result in a version which is ready for CE mark following the directive of an in-vitro medical device. In order to perform the clinical studies, Spotlab has partnered with different european and international health institutions, in Europe, Africa, Asia and Latinamerica. As a result, 3 clinical protocols have been co-developed and submitted for approval to the ethical committees covering three use cases - screening, remote diagnosis and training-, and a range of diseases from haematology to neglected tropical diseases. The study of these opportunities has allowed us to advance the market access strategy. These studies are expected to be executed during the second part of the project, which will demonstrate the clinical performance of the Spotlab digital health ecosystem.